This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Erik Ladomersky, PhD
Advertisement
Articles by Erik Ladomersky, PhD
Advertisement
Latest Updated Articles
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementPublished: March 13th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
4
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
5
